AlphaStocks
6.8
Consider Buy

Elevance Health, Inc. (ELV)

Health Care / Managed Health Care

S&P 500

$374.59

Middle of the pack. No strong signal either way.

Consider Buy

Score based on 5 of 5 models — high confidence

#97out of 1126 in Health Care

Is Elevance Health, Inc. a Good Investment in 2026?

Elevance Health, Inc. (ELV) scores 6.8 out of 10 on AlphaStocks' composite model, earning a Consider Buy rating. The Piotroski model rates Elevance Health, Inc. as Attractive (6/9). The Lynch model is the least favorable, rating it Neutral. Elevance Health, Inc. currently trades below its estimated fair value of $483, suggesting potential upside. Elevance Health, Inc. ranks #97 out of 1126 stocks in the Health Care sector.

This summary is algorithmically generated and is not financial advice.

Key Metrics

P/E14.9ROE12.9Market Cap83BDiv Yield2.2

Estimated Fair Value

$482.7622% below

Fair value above market price. P/E of 15x is moderate for this quality level.

Model-based estimate, not a price target.

5-Model Analysis

Each model evaluates this stock from a different angle. Combined, they form the composite score above.

Piotroski

Attractive

6/9

Buffett

Attractive

Business quality & competitive moat

Graham

Neutral

2% below fair value

Lynch

Neutral

PEG 1.2 · Stalwart

Greenblatt

Attractive

Top half (rank 38%)

Frequently Asked Questions

Is Elevance Health, Inc. (ELV) a good investment?
Based on AlphaStocks' composite analysis, Elevance Health, Inc. (ELV) scores 6.8 out of 10, earning a Consider Buy rating. This is a middle-of-the-pack score with no strong signal either way. Fair value above market price. P/E of 15x is moderate for this quality level.
What is Elevance Health, Inc.'s Piotroski F-Score?
Elevance Health, Inc.'s Piotroski F-Score status is Attractive. The raw score is 6/9. The Piotroski F-Score evaluates financial health using 9 fundamental signals including profitability, leverage, and operating efficiency.
Is ELV overvalued or undervalued?
Based on AlphaStocks' model-based fair value estimate of $483, ELV appears undervalued. The stock currently trades 22% below its estimated fair value. Fair value above market price. P/E of 15x is moderate for this quality level.
How does ELV compare to other Health Care stocks?
Elevance Health, Inc. ranks #97 out of 1126 stocks in the Health Care sector, placing it in the top 9% of its sector by composite score. This is a strong position relative to sector peers.
What do investment models say about ELV?
AlphaStocks evaluates ELV using five proven investment models. Piotroski: Attractive; Buffett: Attractive; Graham: Neutral; Lynch: Neutral; Greenblatt Magic Formula: Attractive. These models are combined into a single composite score of 6.8/10.

Similar Stocks

PARRAZNFTI

Compare ELV with

ELV vs PARRELV vs AZNELV vs FTI

Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer